System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Daniel Larocque, PhD is an expert in Infectiology at Sanofi Pasteur (France). Daniel Larocque has authored 16 publications, the most recent in 2026. SLR score: 47 (community average: 125). How the SLR is computed.

LeadR Profile

Daniel Larocque, PhD Sanofi Pasteur France
47 ScienceLeadR Reputation 47

Unlock

Register Login
Network Map

Infectiology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Sanofi Vaccines: 2015 to present

CEO: PairImmune inc. 2015

GSK Vaccines: 2007 to 2015

UCLA/Cedars Sinai Medical Center: 2004-2007

McGill University (Experiment Medicine PhD diploma): 2000-2004

NRC-Canada: 1999-2000

INRS Institut Armand-Frappier (MSc diploma): 1997-1999

Université de Sherbrooke (BSc diploma): 1993-1997

Organizations

Career arc: 2007 - 2026
Source: PubMed

Sanofi Vaccines

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 16

Citations

Citations: 183 1st author: 2 Last author: 2 Unique author: 0

Main journals

FASEB J 2
NPJ Vaccines 2
CRC Press eBooks 1
Clin Dev Immunol 1
Clin Transl Immunology 1

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Variability in the TLR3 type I interferon pathway is predictive of RNA vaccine responses.
PMID 42139359 — cytokines, cells, vaccines, viruses, immunity, interleukin-2, interferon type i, rna		Sci Adv20260
Author Correction: SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidate.
PMID 39915492 — vaccines, liposomes		NPJ Vaccines20250
SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidate.
PMID 39702373 — cytokines, cells, vaccines, liposomes, ethanol		NPJ Vaccines20240
Ranking of Curricular Content by Pharmacy Students and Community Pharmacists.
PMID 35893709 — curriculum, injections, pharmacists, communication, cross-sectional studies, students, pharmacy		Pharmacy (Basel)20224
Whole-blood cytokine secretion assay as a high-throughput alternative for assessing the cell-mediated immunity profile after two doses of an adjuvanted SARS-CoV-2 recombinant protein vaccine candidate.
PMID 35035955 — cytokines, cells, sars-cov-2, blood, vaccines, immunity, cellular, aged, immunity, severe acute respiratory syndrome-related coronavirus, recombinant proteins		Clin Transl Immunology202220

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS